Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1997 Oct;50(10):801–804. doi: 10.1136/jcp.50.10.801

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.

P J van Diest 1, P van Dam 1, S C Henzen-Logmans 1, E Berns 1, M E van der Burg 1, J Green 1, I Vergote 1
PMCID: PMC500257  PMID: 9462258

Full text

PDF
801

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. J., Tiniakos D. G., McIntosh G. G., Autzen P., Henry J. A., Thomas M. D., Reed J., Horne G. M., Lennard T. W., Angus B. Retinoblastoma protein in human breast carcinoma: immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues. J Pathol. 1996 Sep;180(1):65–70. doi: 10.1002/(SICI)1096-9896(199609)180:1<65::AID-PATH607>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  2. Baak J. P., Chin D., van Diest P. J., Ortiz R., Matze-Cok P., Bacus S. S. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Lab Invest. 1991 Feb;64(2):215–223. [PubMed] [Google Scholar]
  3. Bosman F. T., de Goeij A. F., Rousch M. Quality control in immunocytochemistry: experiences with the oestrogen receptor assay. J Clin Pathol. 1992 Feb;45(2):120–124. doi: 10.1136/jcp.45.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fleege J. C., van Diest P. J., Baak J. P. Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry. Lab Invest. 1990 Aug;63(2):270–275. [PubMed] [Google Scholar]
  5. Fleege J. C., van Diest P. J., Baak J. P. Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Refinement and multiobserver evaluation. Anal Quant Cytol Histol. 1993 Aug;15(4):281–289. [PubMed] [Google Scholar]
  6. Fritz P., Wu X., Tuczek H., Multhaupt H., Schwarzmann P. Quantitation in immunohistochemistry. A research method or a diagnostic tool in surgical pathology? Pathologica. 1995 Jun;87(3):300–309. [PubMed] [Google Scholar]
  7. Gaskell D. J., Hawkins R. A., Sangsterl K., Chetty U., Forrest A. P. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet. 1989 May 13;1(8646):1044–1046. doi: 10.1016/s0140-6736(89)92445-8. [DOI] [PubMed] [Google Scholar]
  8. Gundersen H. J., Osterby R. Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'. J Microsc. 1981 Jan;121(Pt 1):65–73. doi: 10.1111/j.1365-2818.1981.tb01199.x. [DOI] [PubMed] [Google Scholar]
  9. Hall P. A., Richards M. A., Gregory W. M., d'Ardenne A. J., Lister T. A., Stansfeld A. G. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol. 1988 Mar;154(3):223–235. doi: 10.1002/path.1711540305. [DOI] [PubMed] [Google Scholar]
  10. Henson D. E. Loss of p53-immunostaining intensity in breast cancer. J Natl Cancer Inst. 1996 Aug 7;88(15):1015–1016. doi: 10.1093/jnci/88.15.1015. [DOI] [PubMed] [Google Scholar]
  11. Jacobs T. W., Prioleau J. E., Stillman I. E., Schnitt S. J. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst. 1996 Aug 7;88(15):1054–1059. doi: 10.1093/jnci/88.15.1054. [DOI] [PubMed] [Google Scholar]
  12. Kay E. W., Walsh C. J., Cassidy M., Curran B., Leader M. C-erbB-2 immunostaining: problems with interpretation. J Clin Pathol. 1994 Sep;47(9):816–822. doi: 10.1136/jcp.47.9.816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Michalides R., van Veelen N., Hart A., Loftus B., Wientjens E., Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 1995 Mar 1;55(5):975–978. [PubMed] [Google Scholar]
  14. Oudejans J. J., Jiwa N. M., Kummer J. A., Ossenkoppele G. J., van Heerde P., Baars J. W., Kluin P. M., Kluin-Nelemans J. C., van Diest P. J., Middeldorp J. M. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood. 1997 Feb 15;89(4):1376–1382. [PubMed] [Google Scholar]
  15. Polkowski W., Meijer G. A., Baak J. P., ten Kate F. J., Obertop H., Offerhaus G. J., van Lanschot J. J. Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus. Anal Quant Cytol Histol. 1997 Jun;19(3):246–254. [PubMed] [Google Scholar]
  16. Visscher D. W., Sarkar F., Tabaczka P., Crissman J. Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma. Mod Pathol. 1996 Jun;9(6):642–646. [PubMed] [Google Scholar]
  17. van Diest P. J., Michalides R. J., Jannink L., van der Valk P., Peterse H. L., de Jong J. S., Meijer C. J., Baak J. P. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol. 1997 Feb;150(2):705–711. [PMC free article] [PubMed] [Google Scholar]
  18. van Diest P. J., Weger D. R., Lindholm J. Reproducibility of subjective immunoscoring of steroid receptors in breast cancer. Anal Quant Cytol Histol. 1996 Oct;18(5):351–354. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES